Suboxone Market, by Type, by Formulation, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Suboxone is a prescription opioid medication that is used to inhibit the effects of opioid medications, such as pain relief, which can lead to opioid dependence. Suboxone can be used alone or in combination with other drugs to treat opioid addiction. Suboxone belongs to a drug class known as opioid antagonists, analgesics, and opioid partial agonists. Suboxone is composed of buprenorphine and naloxone. Buprenorphine is an opioid medicine, sometimes known as a narcotic. Naloxone counteracts the benefits of opioid medications, such as pain relief and feelings of well-being, which can lead to opioid dependence.

Market Dynamics

The increasing product launches for suboxone is expected to drive the growth of global suboxone market over the forecast period. In September 2018, Lannett Co Inc., a global manufacturer of pharmaceutical products, launched five products that include Buprenorphine plus Naloxone Sublingual tablets, and others.

Moreover, increasing prescription of opioids in certain regions is expected to drive the market growth over the forecast period. For instance, a research published by EclinicalMedicine, a new open access clinical journal, in November 2021 stated that the U.K. had the highest consumption rate of prescription opioids for pain management per capita in the world, despite declining rates globally.

Furthermore, increasing prevalence of chronic pain is expected to drive the growth of global suboxone market over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention in September 2018, stated that an estimated 20.4% of the U.S. adults (50.0 million) had chronic pain and 8.0% of the U.S. adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age in 2016.

Key features of the study:

This report provides an in-depth analysis of the global suboxone market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global suboxone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Indivior PLC, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Rhodes Pharmaceuticals L.P., Alvogen, Sun Pharmaceutical Industries Ltd., Alkem Labs, and Hikma Pharmaceuticals PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global suboxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global suboxone market

Detailed Segmentation:

Global Suboxone Market, By Type:
- Branded
- Generics
Global Suboxone Market, By Formulation:
- Tablets
- Films
Global Suboxone Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Suboxone Market, By Region:
- North America
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Country
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - By Type
  - Branded
  - Generics
  - By Formulation
  - Tablets
  - Films
  - By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - By Region/Country
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
- Indivior PLC.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Dr. Reddy's Laboratories Ltd.
- Amneal Pharmaceuticals LLC.
- Mylan N.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt
- Lannett Co Inc.
- Rhodes Pharmaceuticals L.P.
- Alvogen
- Sun Pharmaceutical Industries Ltd.
- Alkem Labs
- Hikma Pharmaceuticals PLC

"*" marked represents similar segmentation in other categories in the respective section

Product Code: CMI5000

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Formulation
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
New Product Launches
Regulatory Scenario
PEST Analysis
PORTER's Analysis
Key Developments
Brand Analysis
Strategic Agreement, Merger And Acquisitions

4. Global Suboxone Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Suboxone Market, By Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Suboxone Market, By Formulation, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Films
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Suboxone Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Suboxone Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa

9. Competitive Landscape

Indivior PLC.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Dr. Reddy's Laboratories Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Amneal Pharmaceuticals LLC.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mylan N.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Mallinckrodt
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Lannett Co Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Rhodes Pharmaceuticals L.P.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alvogen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sun Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Alkem Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Hikma Pharmaceuticals PLC
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

10. Section

Research Methodology
About Us

Suboxone Market, by Type, by Formulation, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030